Published in Br J Clin Pharmacol on April 01, 1996
Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol (1999) 1.18
Urinary tract infections in pregnancy. Can Fam Physician (2008) 1.04
Bullous fixed drug eruption to ciprofloxacin: a case report. J Clin Diagn Res (2013) 1.02
The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know? J Clin Aesthet Dermatol (2010) 0.83
Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones. Antimicrob Agents Chemother (2014) 0.83
Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature. J Athl Train (2014) 0.82
Ex vivo human placental transfer of trovafloxacin. Infect Dis Obstet Gynecol (2000) 0.81
New insights in extracellular matrix remodeling and collagen turnover related pathways in cultured human tenocytes after ciprofloxacin administration. Muscles Ligaments Tendons J (2013) 0.78
Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report. J Med Case Rep (2009) 0.78
Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions. Yonsei Med J (2010) 0.77
Gonorrhoea. BMJ Clin Evid (2007) 0.77
Fluoroquinolone-associated tendinopathy: a case report. J Med Case Rep (2007) 0.76
Gonorrhoea. BMJ Clin Evid (2011) 0.76
Gonorrhoea. BMJ Clin Evid (2014) 0.75
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Safety of long-term lamotrigine in epilepsy. Epilepsia (1997) 2.92
The VAMP Research multi-purpose database in the U.K. J Clin Epidemiol (1995) 2.37
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiol Drug Saf (1997) 2.33
Visual field defect associated with vigabatrin: observational cohort study. BMJ (1999) 2.19
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation (2001) 2.17
Fibrinolytic activity and coronary-artery disease. Lancet (1968) 2.10
Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract (1999) 1.89
Review of yellow cards--1986 and 1987. Br Med J (Clin Res Ed) (1988) 1.81
Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. Br Med J (Clin Res Ed) (1987) 1.69
Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatr Scand (2010) 1.67
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ (2000) 1.62
Costs of seeking ethics approval before and after the introduction of multicentre research ethics committees. J R Soc Med (2000) 1.59
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Thorax (1998) 1.58
Prescription-event monitoring of 10,401 patients treated with fluvoxamine. Br J Psychiatry (1994) 1.58
Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol (1988) 1.56
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ (1988) 1.55
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients. J Hum Hypertens (2006) 1.51
A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women. J Clin Epidemiol (1994) 1.39
Advanced medical courses at the Royal Society of Medicine. J R Soc Med (1991) 1.39
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf (1997) 1.38
Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study). Pharmacoepidemiol Drug Saf (1997) 1.37
Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study. BMJ (1998) 1.34
The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients. Br J Urol (1996) 1.33
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol (1998) 1.31
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol (1998) 1.23
The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiol Drug Saf (1999) 1.19
Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol (1993) 1.16
Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol (2000) 1.10
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol (2001) 1.10
Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract (1999) 1.09
Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf (1999) 1.00
United Kingdom experience with alendronate and oesophageal reactions. Br J Gen Pract (1998) 0.94
Review of yellow cards (1986): report to the Committee on the Safety of Medicines. Br J Clin Pharmacol (1988) 0.93
Differentiation of constrictive pericarditis from restrictive cardiomyopathy by Doppler transesophageal echocardiographic measurements of respiratory variations in pulmonary venous flow. J Am Coll Cardiol (1993) 0.93
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol (2000) 0.93
Prescription-event and other forms of epidemiological monitoring of side-effects in the UK. Clin Exp Allergy (1999) 0.92
Whither therapeutics? An enquiry into drug use from historical principles: Part I. J R Soc Med (1986) 0.92
The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study. Br J Clin Pharmacol (2000) 0.90
Effect of age, sex, and diurnal variation on the human fibrinolystic system. J Clin Pathol (1967) 0.89
Prescription-event monitoring: methodology and recent progress. J Clin Epidemiol (1990) 0.89
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care (2000) 0.89
Relation of serum triglyceride levels to survival after coronary artery bypass grafting. Am J Cardiol (2000) 0.88
Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding. BMJ (2000) 0.88
Transesophageal Doppler echocardiography of pulmonary venous flow: a new marker of mitral regurgitation severity. J Am Coll Cardiol (1991) 0.88
Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol (1999) 0.86
ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring. Eur J Clin Pharmacol (1996) 0.86
Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label. BMJ (1998) 0.86
HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation. Circulation (2000) 0.85
Danger of interaction between ciprofloxacin and theophylline. Br Med J (Clin Res Ed) (1988) 0.84
Safety profile of nicorandil--prescription-event monitoring (PEM) study. Pharmacoepidemiol Drug Saf (1999) 0.84
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs? Pharmacoepidemiol Drug Saf (1998) 0.83
QT lengthening and life-threatening arrhythmias associated with fexofenadine. Br J Gen Pract (2000) 0.83
Effects of mitral stenosis on pulmonary venous flow as measured by Doppler transesophageal echocardiography. Am J Cardiol (1993) 0.82
Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis. J Clin Pathol (1966) 0.80
Antiplasmin activity of electrophoretically separated human serum fractions. J Clin Pathol (1966) 0.80
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring. Drug Saf (2001) 0.80
Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis (2001) 0.78
Front line workers in long-term care: the effect of educational interventions and stabilization of staffing ratios on turnover and absenteeism. J Am Med Dir Assoc (2003) 0.78
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study. Eur J Clin Pharmacol (1997) 0.78
Comparison of Doppler and two-dimensional echocardiography for assessment of pericardial effusion. Am J Cardiol (1992) 0.78
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis. Atherosclerosis (2000) 0.78
Did knowledge, opinions, background, and health authority advice influence early prescribing of the novel Alzheimer's disease drug donepezil in general practice?--national postal survey. Pharmacoepidemiol Drug Saf (1999) 0.78
Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring. Eur J Clin Pharmacol (1995) 0.78
Whither therapeutics? An enquiry into drug use from historical principles: Part II. J R Soc Med (1986) 0.77
Hazards with desensitising vaccines. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M (1988) 0.77
Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group. Pharmacoepidemiol Drug Saf (2001) 0.77
Regional variation in incidence and case fatality of myocardial infarction among young women in England, Scotland and Wales. J Epidemiol Community Health (2000) 0.76
How deadly is the "deadly quartet"? A post-CABG evaluation. J Am Coll Cardiol (2000) 0.76
Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression. Br J Clin Pharmacol (1999) 0.76
Exposure to the operator and patient during short wave diathermy treatments. Health Phys (1982) 0.76
Results of prescription event monitoring study of salmeterol. BMJ (1994) 0.75
Angiotensin converting enzyme inhibitors and asthma. BMJ (1994) 0.75
Reye's syndrome and aspirin. J R Coll Gen Pract (1986) 0.75
Tolerability of alendronate. Figures given in letter were prevalences, not incidences. BMJ (1998) 0.75
Policies on drugs in the new Europe. BMJ (1990) 0.75
Withdrawal of alclofenac (Prinalgin) Br Med J (1979) 0.75
Finasteride and tamsulosin used in benign prostatic hypertrophy: a review of the prescription-event monitoring data. BJU Int (2001) 0.75
Galactorrhoea with moclobemide. Lancet (1998) 0.75
Importance of sampling both pulmonary veins in grading mitral regurgitation by transesophageal echocardiography. J Am Soc Echocardiogr (1993) 0.75
Nefazodone in community use: the results of prescription-event monitoring. Pharmacoepidemiol Drug Saf (1999) 0.75
A clinical trial of polythiazide and guanoxan in the treatment of hypertension. Practitioner (1966) 0.75
Data privacy and confidentiality. Pharmacoepidemiol Drug Saf (1999) 0.75
Dr. Susan Wood. Pharmacoepidemiol Drug Saf (1998) 0.75
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring. Int J Clin Pharmacol Ther (1995) 0.75
Selling patients' data. Lancet (1990) 0.75
Breast implants: the tyranny of the anecdote. J Clin Epidemiol (1995) 0.75
Prescription-event monitoring of 10,895 patients treated with alprazolam. Br J Psychiatry (1991) 0.75
Revision of editorial policy. Pharmacoepidemiol Drug Saf (1998) 0.75
The continuous case seminar. Psychiatry (1967) 0.75